Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop

Cardiovasc DiabetolPublished Expert perspective

Methodological detailstaskforce statement
  • Taskforce statement

Scope

As issued by the authors

Patient-reported outcomes (PROs) in diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) and the relevance of their inclusion in clinical practice guidelines for the management of these conditions

Original publication

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop. Cardiovasc Diabetol. Published 7 February 2025. doi:10.1186/s12933-024-02550-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.